United Biotech Private Limited — Gemcitabine Exporter Profile
Indian Pharmaceutical Exporter · #15 for Gemcitabine · $293.6K export value · DGFT Verified
United Biotech Private Limited is the #15 Indian exporter of Gemcitabine with $293.6K in export value and 57 verified shipments. United Biotech Private Limited holds a 0.6% market share in Gemcitabine exports across 7 countries. The company exports 30 pharmaceutical products worth $7.0M across 7 therapeutic categories.
United Biotech Private Limited — Gemcitabine Export Profile: Buyers & Destinations
Where Does United Biotech Private Limited Export Gemcitabine?
| Country | Value | Shipments | Share |
|---|---|---|---|
| SRI LANKA | $103.8K | 5 | 36.6% |
| MYANMAR | $101.3K | 6 | 35.7% |
| NEPAL | $33.2K | 42 | 11.7% |
| SENEGAL | $21.2K | 2 | 7.5% |
| CAMBODIA | $10.6K | 3 | 3.7% |
| ARMENIA | $10.0K | 6 | 3.5% |
| PANAMA | $3.8K | 1 | 1.4% |
United Biotech Private Limited exports Gemcitabine to 7 countries. The largest destination is SRI LANKA accounting for 36.6% of United Biotech Private Limited's Gemcitabine shipments, followed by MYANMAR (35.7%) and NEPAL (11.7%). These destinations reflect United Biotech Private Limited's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Gemcitabine from United Biotech Private Limited?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| WIN PHARMACY CO LTD | MYANMAR | $101.3K | 6 |
| TRADE SERVICES DFCC BANK | SRI LANKA | $52.0K | 3 |
| PEOPLE S BANK | SRI LANKA | $50.0K | 1 |
| PHARMACIE NATIONALE D'APPROVISIONNE | SENEGAL | $15.3K | 1 |
| M/S. NIKHIL PHARMA PVT. LTD. | NEPAL | $11.9K | 14 |
| PHARMACIE NATIONALE DAPPROVISIONNE | SENEGAL | $5.9K | 1 |
| NIKHIL PHARMA PVT. LTD. | NEPAL | $4.5K | 7 |
| MS NIKHIL PHARMA PRIVATE LIMITED | NEPAL | $4.1K | 4 |
| MSNIKHIL PHARMA PVT LTD | NEPAL | $4.1K | 6 |
| SAK CAM PHARMA CO.,LTD | CAMBODIA | $3.9K | 1 |
United Biotech Private Limited supplies Gemcitabine to 21 buyers globally. The largest buyer is WIN PHARMACY CO LTD (MYANMAR), followed by TRADE SERVICES DFCC BANK (SRI LANKA) and PEOPLE S BANK (SRI LANKA). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Gemcitabine Export Value and How Much Does United Biotech Private Limited Contribute?
India exported $36.6M worth of Gemcitabine through 2,938 shipments from 248 suppliers to 125 countries, serving 676 buyers globally. United Biotech Private Limited contributes $293.6K to this total, accounting for 0.6% of India's Gemcitabine exports. United Biotech Private Limited ships Gemcitabine to 7 countries through 21 buyers.
What Is the Average Shipment Value for United Biotech Private Limited's Gemcitabine Exports?
United Biotech Private Limited's average Gemcitabine shipment value is $5.2K per consignment, based on 57 shipments totaling $293.6K. The largest destination is SRI LANKA (36.6% of United Biotech Private Limited's Gemcitabine exports).
How Does United Biotech Private Limited Compare to Other Indian Gemcitabine Exporters?
United Biotech Private Limited ranks #15 among 248 Indian Gemcitabine exporters with a 0.6% market share. The top 3 exporters are FRESENIUS KABI ONCOLOGY LIMITED ($6.9M), EUGIA PHARMA SPECIALITIES LIMITED ($5.9M), SUN PHARMACEUTICAL INDUSTRIES LIMITED ($5.8M). United Biotech Private Limited processed 57 shipments to 7 destination countries.
What Gemcitabine Formulations Does United Biotech Private Limited Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| BIOGEM 1000 (GEMCITABINE INJECTION 1000MG (LYOPHILIZED))(B.NO. GHLB5B1 MFG: 2/25,E:1/27) | $83.4K | 3 |
| BIOGEM 1000GEMCITABINE FOR INJECTION USP 1000MG/VIALBATCH NO:GHLI3B6 MANUFACTURING DT:09/2023EXP DT:08/2025 | $50.0K | 1 |
| BIOGEM 1000MG INJ.(GEMCITABINE FOR INJECTION USP 1000MG/ML) (B.NO. GHLD5B2 M:04/25, E: 03/27) | $50.0K | 1 |
| BIOGEM 200 (GEMCITABINE INJECTION 200MG(LYOPHILIZED)) (B.NO. GHLB5A2 MFG: 2/25,E:1/27) | $17.9K | 3 |
| BIOGEM 1gm,Gemcitabine Inj 1gm,B/N:GHLK2 | $15.3K | 1 |
| BIOGEM 200MG GEMCITABINE FOR INJ 200MG, | $5.9K | 1 |
| BIOGEM 1gm,Gemcitabine for Injection IP | $3.9K | 1 |
| BIOGEM 1 GEMCITABINE INJECTION IP 1GM B.NO.GHLC4B1,MFG.DT. 03/2024,EXP.DT. 02/2026 | $3.9K | 1 |
| BIOGEM 1000 (GEMCITABINE INJ.1000MG) | $3.8K | 1 |
| BIOGEM 1000 GEMCITABINE INJ 1000MG B.NO.GHLC3B2 MANUFACTURING .DT.03/23EXP.DT.02/25 | $3.0K | 1 |
United Biotech Private Limited exports 52 distinct Gemcitabine formulations including tablets, capsules, syrups, and combination drugs. The top formulation is BIOGEM 1000 (GEMCITABINE INJECTION 1000MG (LYOPHILIZED))(B.N with 3 shipments worth $83.4K.
How Does United Biotech Private Limited Compare to Nearest Gemcitabine Exporters?
Exporters ranked immediately above and below #15 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 12 | RR PHARMACEUTICALS PRIVATE LIMITED | $300.0K | 6 | 1 | $50.0K |
| 14 | GETWELL PHARMA INDIA PRIVATE LIMITED | $295.2K | 67 | 5 | $4.4K |
| 15 | UNITED BIOTECH PRIVATE LIMITED ★ | $293.6K | 57 | 7 | $5.2K |
| 13 | INTAS PHARMACEUTICALS LTD | $150.0K | 3 | 3 | $50.0K |
United Biotech Private Limited ranks #15 among 248 Indian Gemcitabine exporters. Average shipment value of $5.2K compared to the market average of $147.4K. The closest competitors by value are RR PHARMACEUTICALS PRIVATE LIMITED and GETWELL PHARMA INDIA PRIVATE LIMITED.
Which Indian Ports Ship Gemcitabine Exports?
| Port | Shipments | % Share |
|---|---|---|
| DELHI AIR CARGO ACC (INDEL4) | 538 | 18.3% |
| SAHAR AIR CARGO ACC (INBOM4) | 393 | 13.4% |
| SAHAR AIR | 370 | 12.6% |
| DELHI AIR | 358 | 12.2% |
| Delhi Air | 131 | 4.5% |
| HYDERABAD ICD (INSNF6) | 88 | 3.0% |
| Bombay Air | 77 | 2.6% |
| NHAVA SHEVA SEA (INNSA1) | 66 | 2.2% |
What Other Oncology Products Does United Biotech Private Limited Export?
United Biotech Private Limited also exports these oncology products. Each links to the detailed product page.
Geopolitical & Trade Policy Impact on United Biotech Private Limited's Gemcitabine Exports
The current geopolitical climate presents both challenges and opportunities for Indian pharmaceutical exporters like United Biotech. The Israel-Iran conflict has escalated tensions in the Middle East, leading to disruptions in Red Sea shipping routes and increased freight costs. The Pharmaceuticals Export Promotion Council of India estimates potential losses between ₹2,500 crore and ₹5,000 crore due to these disruptions, affecting companies reliant on Middle Eastern markets. (telanganatoday.com)
Conversely, the U.S.-China trade tensions have opened avenues for Indian pharmaceutical firms to expand their footprint in the American market. However, recent U.S. tariff policies, including potential increases on pharmaceutical imports, pose a risk to this growth. President Trump's administration has threatened substantial tariff hikes to encourage domestic production, which could impact Indian exporters' competitiveness in the U.S. market. (lemonde.fr)
In the European Union, the implementation of the Falsified Medicines Directive (FMD) necessitates stringent compliance measures for exporters. Indian companies must adapt to these regulatory changes to maintain access to the EU market. The India–EFTA Trade and Economic Partnership Agreement, effective from October 2025, aims to reduce tariffs and promote trade, potentially benefiting exporters like United Biotech. (en.wikipedia.org)
United Biotech Private Limited — Regulatory Compliance & Quality Standards
Compliance with international regulatory standards is paramount for Indian pharmaceutical exporters. The U.S. FDA, WHO, and EU GMP guidelines set rigorous quality benchmarks that companies must meet to access global markets. While specific regulatory events concerning United Biotech are not detailed, adherence to these standards is essential for sustaining export operations.
The evolving quality requirements, including serialization and traceability mandates under the EU FMD, necessitate continuous investment in compliance infrastructure. Indian exporters must proactively adapt to these changes to ensure uninterrupted market access and maintain their reputation for quality.
About United Biotech Private Limited
United Biotech Private Limited exports 30 products worth $7.0M. Beyond Gemcitabine, top products include Ertapenem, Doxorubicin, Voriconazole, Cisplatin, Methylprednisolone. View the complete United Biotech Private Limited profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Gemcitabine — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Gemcitabine shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: United Biotech Private Limited matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 65 individual customs records matching United Biotech Private Limited exporting Gemcitabine, covering 52 formulations to 7 countries via 21 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 125+ countries, 676+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Gemcitabine Export Data from United Biotech Private Limited
Access shipment-level details, pricing data, buyer connections, and competitive analysis for United Biotech Private Limited's Gemcitabine exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
United Biotech Private Limited
Full Company Profile →
30 products · $7.0M total trade · 7 categories
Gemcitabine Stats
Company Overview
Top Products by United Biotech Private Limited
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for United Biotech Private Limited.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Gemcitabine. For current shipment-level data, contact TransData Nexus.